266 Search Results for: marijuana
Dissecting the data
Dr. Barry Sample, Quest Diagnostics, pours through the numbers in his DATIA Focus article “Assessing Drug Use Trends in the United States.”
Dangers of synthetic cannabinoids
Synthetic cannabinoids change frequently and Quest works to stay current with drug-use patterns by adding compounds to our drug test panels.
Webinar insights: Tracking the trends
Dr. Barry Sample, Director of Science and Technology, reviewed key data and insights from the Quest Diagnostics Drug Testing Index.
2014 SAPAA conference
As a platinum sponsor of the SAPAA conference, we couldn't be more excited about this gathering of thought leaders and experts from the industry.
Workforce drug test positivity rate increases
The Quest Diagnostics Drug Testing Index showed the percentage of positive drug tests among American workers has increased for the first time in more than a decade.
Ask the experts: Under the influence
Is oral fluid is the best drug test specimen type for determining whether an employee is under the influence of drugs – particularly marijuana?
Ask the experts: The history of drug testing
Over the past 25 years, drug test positivity rates have continually declined among employers with a drug testing program in place.
Industry leadership – Robust products
When it comes to robust products, an industry leader should be able to provide its customers with a wide array of options.
National Prescription Drug Take-Back Day 2014
By participating in this event, the DEA is contributing to public safety by helping to rid communities of drugs that could lead to accidental overdoses and abuse.
New to drug testing: Synthetic stimulants
Synthetic compounds change frequently and our scientific experts must monitor, and adjust our testing panels to an ever-changing list of substances.
